ARCHIVES

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

Fisher, Redmond Removed Fro Official posts At NSABP

May 13, 1994

Acting NIH Director Says M.D. Anderson President John Mendelsohn Outlines 10-Point Plan For Cancer Research

February 20, 2009

Bosnian Research Trying To Leave, Asks For More Calls

February 5, 1993

Also NCI appoints members of Clinical Trials Working Group to review trials system.

January 9, 2004

NCAB Supports NCI Director’s Call For Increase In Management Funds.

December 8, 2000

FDA Forms Office of Combination Products;

January 10, 2003